Intermolecular (IMI) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
Intermolecular Announces Third Quarter 2017 Financial Results
November 2, 2017 4:18 PM EDTSAN JOSE, Calif., Nov. 2, 2017 /PRNewswire/ --Â Intermolecular, Inc. (NASDAQ: IMI) today reported results for its Third Quarter ended September 30, 2017.
Results Highlights:
Positive third quarter adjusted EBITDA on 7% sequential revenue growth Third quarter total revenue of $8.6 million Five new contracts signed during the quarter"We are delighted to report our achievement of positive adjusted EBITDA ahead of schedule," said Chris Kramer, president and CEO of Intermolecular. "Our return to profitability is due to the combination of expanding relationships with existing... More



